Core Viewpoint - The collaboration between Haizheng Pharmaceutical and Shengzhao Pharmaceuticals aims to establish a joint venture focused on complex injectable drugs in Taizhou, Zhejiang Province [1] Group 1: Investment Details - Haizheng Pharmaceutical will invest 495 million yuan, holding a 45% stake in the joint venture [1] - Shengzhao Pharmaceuticals will invest 605 million yuan, holding a 55% stake in the joint venture [1] Group 2: Business Focus - The joint venture will primarily engage in the research, production, and commercialization of 11 complex injectable products, including generic drugs and improved new drugs [1] - Haizheng Pharmaceutical will have the priority cooperation rights for future related products from Shengzhao Pharmaceuticals [1]